Lumira-sponsored SPAC seeks $100m from Nasdaq IPO

LAVA Medtech Acquisition Corp, a special purpose acquisition corporation, has priced its initial public offering on the Nasdaq Global Market to raise $100 million.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this